PATENT CLAIM ANALYSIS

Application Number: 16331920
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "261100"]

Abstract:
Triazolo(4,5-d)pyrimidine derivatives for use in treatment or prevention of bacterial infection in a host mammal in need of such treatment or use as inhibitor of biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers.

Claim (Index 1):
A Triazolo(4,5-d)pyrimidine derivative of formula (I): wherein R 1  is C 3-5  alkyl optionally substituted by one or more halogen atoms; R 2  is a phenyl group, optionally substituted by one or more halogen atoms; R 3  and R 4  are both hydroxyl; R is XOH, wherein X is CH 2 , OCH 2 CH 2 , or a bond; or a pharmaceutical acceptable salt or solvate thereof, or a solvate of such a salt provided that when X is CH 2  or a bond, R 1  is not propyl; when X is CH 2  and R 1  is CH 2 CH 2 CF 3 , butyl or pentyl, the phenyl group at R 2  must be substituted by fluorine; when X is OCH 2 CH 2  and R 1  is propyl, the phenyl group at R 2  must be substituted by fluorine.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11841030', '11980907', '11981071', '14958619', '16025170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7559081965123738
- 35 USC 102 Novelty (BERT): 0.5250135762466224
- Combined Prediction Score: 0.7328187344857987
- Mean Citation Score: 263.689836
- Max Citation Score: 313.5044
- Similarity Product: 240.70605392374992

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test